Vanguard Portfolio Management
NUVB icon

Vanguard Portfolio Management’s Nuvation Bio NUVB Stock Holding History

Vanguard Portfolio Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Buy
2,688,666
+413,220
+18% +$2.02M ﹤0.01% 2064
2026
Q1 		$9.76M Buy
+2,275,446
New +$12.7M ﹤0.01% 2121

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Vanguard Portfolio Management's NUVB Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Nuvation Bio (NUVB) stake by 18% in Q2 2026, buying an estimated $2.02M and bringing the position to 2,688,666 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Vanguard Portfolio Management first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 221 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Vanguard Portfolio Management held 2,688,666 shares of Nuvation Bio worth $15.3M as of Q2 2026.
  • Vanguard Portfolio Management bought 413,220 Nuvation Bio shares in Q2 2026, an estimated $2.02M.
  • Nuvation Bio made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2064 holding.
  • Vanguard Portfolio Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 221 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.